Global Hematology Analyzers and Reagents Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Reagents, Instruments), By End User (Diagnostic laboratories, Hospitals & Clinics, Research institutes, and Others), and by Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2022-2030
KEY MARKET INSIGHTS
The Global Hematology Analyzers and Reagents Market size was valued at USD 8.2 billion in 2021 and is expected to grow by USD 13.87 billion in 2030 at a CAGR of 7.6% during the forecast period. Hematology is the branch of medicine that studies, diagnoses, and treats blood disorders. It examines red blood, white blood cells, bone marrow, platelets, and lymph nodes for problems. Hematology also deals with plasma, the liquid component of blood. Leukemia, anemia, blood transfusion, myelofibrosis, malignant lymphomas, and bone marrow organ transplant are all blood-related disorders.
The innovative product introductions by leading players are expected to boost the worldwide hematology analyzer and reagents market growth during the forecast period. Furthermore, increased patient awareness of chronic diseases and the need of keeping good health are expected to improve the worldwide hematology analyzers and reagent market potential.
COVID-19 ANALYSIS
Hematology indicators are becoming increasingly important in the assessment of COVID-19 all over the world. Several studies are being conducted in research institutions, and many hospitals have begun to use hematology analyzers to screen and monitor COVID-19 patients in order to prevent the virus from spreading. Furthermore, according to a study published in Physiological Review-Journal, high rates of enzyme loss of blood clot prevention could be a common risk factor for COVID-19. Furthermore, given the pandemic's rapid spread and limited literature, the proper treatment and management of Coronavirus (COVID-19) infection in patients with hematological problems may be difficult.
LATEST TREND
Rapid Technological Advancements Propel Market Growth
The hematology analyzers and reagents market is likely to be driven by rising adoption rates of automated hematology instruments and rising demands for high sensitivity point-of-care (POC) hematology testing. Rapid technological advancements, such as the development of basic flow cytometry technologies and the introduction of high throughput hematology analyzers, are also projected to have a positive effect on the market growth.
DRIVING FACTORS
Rising Burden of Blood Disorders Boost Market Growth
An increase in the occurrence of blood illnesses such as anemia, hemorrhagic conditions, blood malignancies, and blood infections is a prominent driver driving market expansion. Furthermore, rising demand for automated hematology analyzers, and increased preference for high sensitivity hematology analyzers all contribute to the market's growth. Growth potential in emerging economies is projected to be beneficial for participants in the haematology analyzer market.
RESTRAINTS
High Costs of Haematology Analyzers
The high costs of haematology analyzers, as well as intense competition among current players, are limiting the worldwide haematology analyzers and reagent market's growth. Furthermore, the market is hampered by demanding and time-consuming regulatory procedures for hematological instruments.
SEGMENTATION
The Global Hematology Analyzers and Reagents Market is segmented by Product Type, End-user, and Region. Based on the Product Type, the market is categorized into Reagents, Instruments. Based on End-user, the market is categorized into Diagnostic laboratories, Hospitals & Clinics, Research institutes, and others. Based on the region, the market is categorized into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
REGIONAL INSIGHTS
The Global Hematology Analyzers and Reagents Market is categorized into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
North America is expected to dominate the worldwide hematology analyzer and reagents market owing to the strong presence of key companies and rising investment to create novel and more correct result-generating medical equipment. Due to an increase in the number of diagnostic clinics and increased awareness of hematological illnesses, Europe is expected to take the lead in the worldwide hematology analyzers and reagents market. Because of the rising frequency of hematological illnesses among the patient population, the worldwide market opportunity is expected to be greatest in the undeveloped areas of Asia Pacific.
LIST OF KEY COMPANIES PROFILED:
- Erba Mannheim
- Siemens
- Beckman Coulter, Inc.
- Sysmex
- Bio-Rad Laboratories, Inc.
- Abbott
- Ortho Clinical Diagnostics.
- F. Hoffmann-La Roche Ltd
- PixCell Medical Technologies Ltd.
KEY INDUSTRY DEVELOPMENTS:
November 2018, The US Food and Drug Administration granted PixCell Medical Technologies Ltd. 510(k) approval for its HemoScreen hematological analyzer for point-of-care use.
March 2018, Roche's Cobas m 511 hematological analyzer was cleared by the US FDA.
May 2019, The FDA announced a Class 1 device recall for Beckman Coulter's DxH 800, DxH 600, and DxH 900 hematology analyzers due to erroneous results.
SEGMENTATION
By Product Type
- Reagents
- Instruments
By End-user
- Diagnostic laboratories
- Hospitals & Clinics
- Research institutes
- Others
By Region
- North America- U.S., Mexico, Canada
- Europe- UK, France, Germany, Italy, Spain, Rest of Europe
- Asia-Pacific- China, Japan, India, South Korea, Rest of Asia Pacific
- South America- Brazil, Argentina, Colombia, Rest of South America
- The Middle East and Africa- GCC, South Africa, Rest of Middle East & Africa
ARE YOU SEEKING COMPREHENSIVE INSIGHT ON VARIOUS
MARKETS?
CONTACT OUR EXPERTS TODAY
Speak to an Expert
Global Hematology Analyzers and Reagents Market
- June-2022
- 1 4 0
- Global
- Healthcare-Medical-Devices-Biotechnology
Related Research
2022-2030 Global and Regional B-Cell Non-Hodgkin`s Lymphoma (NHL) Treatment Industry Production, Sa
February-2021
2022-2030 Global and Regional Organ Transplant Diagnostics Industry Production, Sales and Consumpti
February-2021
2022-2030 Global and Regional Prostacyclin Drug Industry Production, Sales and Consumption Status a
February-2021
2022-2030 Global and Regional Spinal and Bulbar Muscular Atrophy Treatment Industry Production, Sal
February-2021
2% Chlorhexidine Gluconate (CHG) Cloths-Global Market Status & Trend Report 2022-2030 Top 20 Countri
April-2021
2021-2027 Global and RegioAnal Nasal Gels Industry Production, Sales and Consumption Status and Pros
February-2021
2021-2027 Global and Regional 2019-nCoV Detection Server Industry Production, Sales and Consumption
February-2021
2021-2027 Global and Regional ? Collagen Quantitative Determination Kit Industry Production, Sales a
February-2021
2021-2027 Global and Regional Anti-TNF Monoclonal Antibody Industry Production, Sales and Consumptio
February-2021